Explore Products
Tumor Cell Lines

H1975

  • 237
The line was established in July 1988. The tissue donor was a non-smoker.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Product Code

H1975; H-1975; NCIH1975

Species

Human

Cat.No

ABC-TC521S

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Cell Type

Epithelial

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Lung

Disease

Adenocarinoma

Storage

Liquid Nitrogen

Product Type

Human Lung Cancer Cell Lines

Description

H1975
H1975 is a human non-small cell lung cancer (NSCLC) cell line derived from the lung tissue of a White female patient with NSCLC. This epithelial-like cell line exhibits adherent culture properties with a doubling time of approximately 40 hours. Genetically, it harbors two key EGFR mutations, including L858R and T790M. In addition, H1975 carries a TP53 mutations, contributing to its oncogenic potential. The cell line demonstrates tumorigenic potential in immunocompromised mice, forming subcutaneous xenografts, making them a well-established model for EGFR-driven oncogenesis and therapeutic resistance.
View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • H1975 is a widely used model in immuno-oncology and lung cancer research, particularly for investigating epidermal growth factor receptor (EGFR) mutation-driven tumorigenesis and TKI resistance mechanisms. Its dual EGFR mutations make it an ideal platform for preclinical evaluation of EGFR tyrosine kinase inhibitors and combination therapies aiding in the development of strategies to overcome this resistance. Additionally, they are employed in 3D cell culture models, xenograft models, and immune-oncology research to assess drug responses in a physiologically relevant context. Therefore, H1975 remains a cornerstone in development of potential therapeutic interventions for EGFR-mutant NSCLC.

Inquiring H1975

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button